Evolving role of FDG-PET-based global disease assessment and detection of response to nivolumab treatment in patients with non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Seraj, Siavash Mehdizadeh [2 ]
Jahangiri, Pegah [2 ]
Zadeh, Mahdi Zirakchian [1 ]
Kalboush, Eman [2 ]
Werner, Thomas [2 ]
Alavi, Abass [2 ]
Hunt, Stephen [2 ]
机构：
[1] Childrens Hosp Philadelphia, Dept Radiol, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2019年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1347
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Treatment of non-small cell lung cancer (NSCLC)
    Zarogoulidis, Konstantinos
    Zarogoulidis, Paul
    Darwiche, Kaid
    Boutsikou, Efimia
    Machairiotis, Nikolaos
    Tsakiridis, Kosmas
    Katsikogiannis, Nikolaos
    Kougioumtzi, Ioanna
    Karapantzos, Ilias
    Huang, Haidong
    Spyratos, Dionysios
    JOURNAL OF THORACIC DISEASE, 2013, 5 : S389 - S396
  • [22] Role of FDG PET scans in staging, response assessment and follow-up care for non-small cell lung cancer
    Cuaron, John
    Dunphy, Mark
    Rimner, Andreas
    FRONTIERS IN ONCOLOGY, 2013, 2
  • [23] Mid-treatment FDG-PET predicts disease progression in patients with non-small cell lung cancer
    Olson, M. R.
    Weerasuriya, D. K.
    Wakelee, H. A.
    Quon, A.
    Maxim, P. G.
    Le, Q.
    Graves, E. E.
    Loo, B. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S504 - S504
  • [24] Inter-method Variability of [18F]FDG PET Metabolic Response Assessment of Non-small Cell Lung Cancer (NSCLC)
    Wang, J.
    Wong, K.
    Frey, K.
    Piert, M.
    Kong, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S625 - S625
  • [25] FDG-PET in the evaluation of response to nivolumab in recurrent non-small-cell lung cancer
    Mitsunori Higuchi
    Yuki Owada
    Takuya Inoue
    Yuzuru Watanabe
    Takumi Yamaura
    Mitsuro Fukuhara
    Takeo Hasegawa
    Hiroyuki Suzuki
    World Journal of Surgical Oncology, 14
  • [26] FDG-PET in the evaluation of response to nivolumab in recurrent non-small-cell lung cancer
    Higuchi, Mitsunori
    Owada, Yuki
    Inoue, Takuya
    Watanabe, Yuzuru
    Yamaura, Takumi
    Fukuhara, Mitsuro
    Hasegawa, Takeo
    Suzuki, Hiroyuki
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2016, 14
  • [27] The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab
    Bauckneht, Matteo
    Genova, Carlo
    Rossi, Giovanni
    Rijavec, Erika
    Dal Bello, Maria Giovanna
    Ferrarazzo, Giulia
    Tagliamento, Marco
    Donegani, Maria Isabella
    Biello, Federica
    Chiola, Silvia
    Zullo, Lodovica
    Raffa, Stefano
    Lanfranchi, Francesco
    Cittadini, Giuseppe
    Marini, Cecilia
    Lopci, Egesta
    Sambuceti, Gianmario
    Grossi, Francesco
    Morbelli, Silvia
    CANCERS, 2021, 13 (13)
  • [28] The Role of Targeted Agents in the Treatment of Elderly Patients with Non-Small Cell Lung Cancer (NSCLC)
    Taofeek K. Owonikoko
    Suresh Ramalingam
    Current Treatment Options in Oncology, 2008, 9 : 313 - 325
  • [29] The Role of Targeted Agents in the Treatment of Elderly Patients with Non-Small Cell Lung Cancer (NSCLC)
    Owonikoko, Taofeek K.
    Ramalingam, Suresh
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2008, 9 (4-6) : 313 - 325
  • [30] Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease
    Farrell, MA
    McAdams, HP
    Herndon, JE
    Patz, EF
    RADIOLOGY, 2000, 215 (03) : 886 - 890
12345